U.S.-Israeli Talks Over Pharmaceutical Intellectual Property Regime Break Down

Law360, New York (December 2, 2004, 12:00 AM EST) -- Talks between U.S. and Israeli officials over pharmaceutical intellectual property rights have collapsed amid increasing tension between multinational brand-name drug makers and Israel’s burgeoning generics industry.

Israeli Minister of Industry Trade and Labor Ehud Olmert is returning to Israel empty-handed after a long meeting with U.S. Trade Representative Robert Zoellick and a round of marathon talks by the two countries' negotiating teams ended in failure, the Globes business daily reported.

The protracted dispute is weighing heavily on trade relations between the two countries, and the failure...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.